|
|
Evaluation analysis of pharmaceutical intervention on perioperative antibiotic use in patients with typeⅠincision |
HE Zhao-hong1 LI Jie-mei1 YOU Qi-sen2 WU Yong-hong3 |
1.Clinical Pharmacy,Maternal and Child Health Hospital of Taishan City in Guangdong Province,Taishan 529200,China;
2.Department of Surgery,Maternal and Child Health Hospital of Taishan City in Guangdong Province,Taishan 529200, China;
3.Department of Breast,Maternal and Child Health Hospital of Taishan City in Guangdong Province,Taishan 529200,China |
|
|
Abstract ObjectiveTo study the evaluation value of pharmaceutical intervention on perioperative antibiotic use in patients with typeⅠ incision.MethodsA total of 200 patients with typeⅠ incision from July 2015 to July 2016 were selected and they were randomly divided into two groups,and there were 100 cases in each group.In the non-intervention group,the perioperative antibiotics were treated with conventional drugs,and the intervention group was not used. The pharmaceutical intervention was used in the intervention group.Rational application rate of antibiotics,average hospitalization time,the average cost of antimicrobial agents,the average cost of hospitalization;the specific situation of irrational use;the quality of life between two groups were compared.ResultsThe rational application rate of antimicrobial agents in the intervention group was 93.00%,and it was higher than that in the non-intervention group(P<0.05).The average hospitalization time,the average cost of antimicrobial agents and the average cost of hospitalization were less than those in the non-intervention group(P<0.05).7 cases with the irrational medication are improper drug selection.And all patients with irrational medication in non-intervention group included drug selection inappropriate 18 cases,12 hours of inappropriate administration,continuous medication time inappropriate 3 cases,the replacement of drugs based on 1 case (some of which patients can occur simultaneously 2 or the above irrational use of drugs).The quality of life was significantly better in the intervention group than that in the untreated group (P<0.05).ConclusionThe effect of pharmacy intervention on the use of antimicrobial agents in the perioperative period of typeⅠ incision is effective,which can effectively improve the rational application rate of antimicrobial agents,shorten the average hospital stay,reduce the cost of hospitalization and antimicrobial expenses,improve the quality of life after surgery,and it is worthy of promotion.
|
|
|
|
|
[1] |
Berglin CE,Laurell G,Bramer T,et al.Magnetic resonance imaging of the middle and inner ear after intratympanic injection of a gadolinium-containing gel[J].Otol Neurotol,2014,35(3):526-532.
|
[2] |
孟菲,姚会枝.药学干预前后该院Ⅰ类切口预防用抗菌药物使用情况对比分析[J].中国卫生产业,2016,13(27):50-52.
|
[3] |
张玉高,李岳平,李玉华,等.药学干预对Ⅰ类切口围术期抗菌药物应用的影响[J].中国药物经济学,2015,10(5):29-30.
|
[5] |
邢文忠,莫红春,段莲,等.昆钢医院2011年至2013年实施抗菌药物专项整治和药学干预的效果分析[J].昆明医科大学学报,2014,35(6):137-141.
|
[7] |
谢育霞,费惠英.Ⅰ类切口手术预防用抗菌药物的药学干预对策分析[J].中国卫生标准管理,2016,7(8):93-94.
|
[8] |
孙雷.骨科Ⅰ类切口手术预防用抗菌药物实施药学干预的效果初步评价[J].中国医药指南,2016,14(25):144-145.
|
[4] |
Riggi G,Castillo M,Fernandez M,et al.Improving compliance with timely intraoperative redosing of antimicrobials in surgical prophylaxis[J].Infect Control Hosp Epidemiol,2014,35(10):1236-1240.
|
[6] |
Knoderer CA,Saft SA,Walker SG,et al.Cefuroxime pharmacokinetics in pediatric cardiovascular surgery patients undergoing cardiopulmonary bypass[J].J Cardiothorac Vasc Anesth,2011,25(3):425-430.
|
[9] |
徐艳华,赵登职.某医院Ⅰ类切口围手术期抗菌药物应用干预调查分析[J].中国处方药,2015,13(10):8-9.
|
[10] |
张华,王辉.普外科四种Ⅰ类切口围手术期预防性应用抗菌药物的干预与成效分析[J].海峡药学,2016,28(8):233-235.
|
[11] |
曹尉尉,蒋红,陈井霞,等.药学干预前后我院Ⅰ类切口围手术期抗菌药物使用及评价[J].海军医学杂志,2013,34(6):388-390.
|
[12] |
段小云.临床药师干预后骨科Ⅰ类切口手术围术期预防性使用抗菌药物分析[J].中国医院用药评价与分析,2014,14(12):1108-1110.
|
[13] |
李兰兰,易石坚,李毅萍,等.行政干预对Ⅰ类切口围术期预防性使用抗菌药物的影响[J].现代生物医学进展,2012,12(21):4113-4117,4162.
|
[14] |
何建平,李慧伟,钟斌,等.药学干预对Ⅰ类切口围手术期抗菌药物应用的影响[J].赣南医学院学报,2013,33(4):543-544.
|
[15] |
吴慧丽,周建军.药学服务对骨科Ⅰ类切口手术预防使用抗菌药物的影响分析[J].北方药学,2013,10(8):133-133.
|
[16] |
崔静静.药学干预对Ⅰ类切口手术预防性使用抗菌药物的影响[J].中国处方药,2016,14(7):37-38.
|
|
|
|